339 related articles for article (PubMed ID: 24370828)
1. Changes in choroidal thickness after systemic administration of high-dose corticosteroids: a pilot study.
Han JM; Hwang JM; Kim JS; Park KH; Woo SJ
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):440-5. PubMed ID: 24370828
[TBL] [Abstract][Full Text] [Related]
2. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
[TBL] [Abstract][Full Text] [Related]
3. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
[TBL] [Abstract][Full Text] [Related]
4. Choroidal vessel diameter in central serous chorioretinopathy.
Yang L; Jonas JB; Wei W
Acta Ophthalmol; 2013 Aug; 91(5):e358-62. PubMed ID: 23647989
[TBL] [Abstract][Full Text] [Related]
5. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
Hamzah F; Shinojima A; Mori R; Yuzawa M
BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855
[TBL] [Abstract][Full Text] [Related]
6. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
[TBL] [Abstract][Full Text] [Related]
7. Choroidal thickness in central serous chorioretinopathy.
Kuroda S; Ikuno Y; Yasuno Y; Nakai K; Usui S; Sawa M; Tsujikawa M; Gomi F; Nishida K
Retina; 2013 Feb; 33(2):302-8. PubMed ID: 23064424
[TBL] [Abstract][Full Text] [Related]
8. CHOROIDAL THICKNESS OF CENTRAL SEROUS CHORIORETINOPATHY SECONDARY TO CORTICOSTEROID USE.
Honda S; Miki A; Kusuhara S; Imai H; Nakamura M
Retina; 2017 Aug; 37(8):1562-1567. PubMed ID: 27787451
[TBL] [Abstract][Full Text] [Related]
9. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.
Pryds A; Larsen M
Acta Ophthalmol; 2012 Dec; 90(8):738-43. PubMed ID: 21586096
[TBL] [Abstract][Full Text] [Related]
10. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease.
Nakayama M; Keino H; Okada AA; Watanabe T; Taki W; Inoue M; Hirakata A
Retina; 2012; 32(10):2061-9. PubMed ID: 23095726
[TBL] [Abstract][Full Text] [Related]
11. Focal choroidal excavation in eyes with central serous chorioretinopathy.
Ellabban AA; Tsujikawa A; Ooto S; Yamashiro K; Oishi A; Nakata I; Miyake M; Akagi-Kurashige Y; Ueda-Arakawa N; Arichika S; Yoshitake S; Takahashi A; Yoshimura N
Am J Ophthalmol; 2013 Oct; 156(4):673-83. PubMed ID: 23831223
[TBL] [Abstract][Full Text] [Related]
12. Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.
Okamoto M; Matsuura T; Ogata N
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):25-32. PubMed ID: 25559505
[TBL] [Abstract][Full Text] [Related]
13. Change of regional choroid thickness after reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Manabe S; Shiragami C; Hirooka K; Izumibata S; Tsujikawa A; Shiraga F
Am J Ophthalmol; 2015 Apr; 159(4):644-51. PubMed ID: 25595669
[TBL] [Abstract][Full Text] [Related]
14. MINERALOCORTICOID RECEPTOR ANTAGONIST TREATMENT IN BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A COMPARATIVE STUDY OF EXUDATIVE AND NONEXUDATIVE FELLOW EYES.
Gergely R; Kovács I; Schneider M; Resch M; Papp A; Récsán Z; Nagy ZZ; Ecsedy M
Retina; 2017 Jun; 37(6):1084-1091. PubMed ID: 27627749
[TBL] [Abstract][Full Text] [Related]
15. Pachychoroid pigment epitheliopathy.
Warrow DJ; Hoang QV; Freund KB
Retina; 2013 Sep; 33(8):1659-72. PubMed ID: 23751942
[TBL] [Abstract][Full Text] [Related]
16. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.
Imamura Y; Fujiwara T; Margolis R; Spaide RF
Retina; 2009; 29(10):1469-73. PubMed ID: 19898183
[TBL] [Abstract][Full Text] [Related]
17. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration.
Switzer DW; Mendonça LS; Saito M; Zweifel SA; Spaide RF
Retina; 2012 Jul; 32(7):1265-71. PubMed ID: 22222760
[TBL] [Abstract][Full Text] [Related]
18. Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy.
Kim SW; Oh J; Kwon SS; Yoo J; Huh K
Retina; 2011 Oct; 31(9):1904-11. PubMed ID: 21878855
[TBL] [Abstract][Full Text] [Related]
19. Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy.
Razavi S; Souied EH; Cavallero E; Weber M; Querques G
Am J Ophthalmol; 2014 Apr; 157(4):852-60. PubMed ID: 24412124
[TBL] [Abstract][Full Text] [Related]
20. SUBFOVEAL CHOROIDAL THICKNESS AND VASCULAR DIAMETER IN ACTIVE AND RESOLVED CENTRAL SEROUS CHORIORETINOPATHY.
Chung YR; Kim JW; Choi SY; Park SW; Kim JH; Lee K
Retina; 2018 Jan; 38(1):102-107. PubMed ID: 28106708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
